SCYNEXIS
SCYX
$2.42
Share price
2.77%
Change (1 day)
-7.82%
Change (1 year)
Categories
SCYNEXIS (SCYX) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $44.14 M
According to SCYNEXIS's latest financial reports the company's total liabilities are $44.14 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
SCYNEXIS - Total liabilities on balance sheet (from 2013 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $84.57 M | 7.63% |
| 2021-12-31 | $78.57 M | -1.5% |
| 2020-12-31 | $79.77 M | 80.26% |
| 2019-12-31 | $44.25 M | 101.68% |
| 2018-12-31 | $21.94 M | -10.21% |
| 2017-12-31 | $24.44 M | -2.13% |
| 2016-12-31 | $24.97 M | 240.97% |
| 2015-12-31 | $7.32 M | 17.35% |
| 2014-12-31 | $6.24 M | -81.28% |
| 2013-12-31 | $33.33 M | 6.02% |
| 2012-12-31 | $31.44 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Galmed Pharmaceuticals
GLMD | $2.75 M | -93.77% | 🇮🇱 Israel |
 Catalyst Pharmaceuticals CPRX | $85.26 M | 93.13% | 🇺🇸 USA |
 Catalent CTLT | $6.26 B | 14,097.38% | 🇺🇸 USA |
 KemPharm KMPH | $29.72 M | -32.68% | 🇺🇸 USA |